Divi’s Labs Q2 net profit rises 17pc to Rs 606 crore
Hyderabad: Hyderabad-based pharmaceuticals company Divi’s Laboratories reported a 16.71 per cent jump in its net profit to Rs 606.46 crore for the quarter ended September 30, 2021. The company had posted a net profit of Rs 519.59 crore for the corresponding period of the previous fiscal. Divi’s Labs reported a total income during the Q2FY22 […]
Updated On - 05:50 PM, Sat - 6 November 21
Hyderabad: Hyderabad-based pharmaceuticals company Divi’s Laboratories reported a 16.71 per cent jump in its net profit to Rs 606.46 crore for the quarter ended September 30, 2021.
The company had posted a net profit of Rs 519.59 crore for the corresponding period of the previous fiscal.
Divi’s Labs reported a total income during the Q2FY22 at Rs 2,006.62 crore as against Rs 1,762.94 in the corresponding period last year.
For the half-year ended 30th September, 2021, the company earned a consolidated total income of Rs 3,996 crore as against Rs 3,506 crore during the previous half-year. Profit after the tax for the current half-year came to Rs 1,164 crore as against Rs 1,012 crore for the previous half-year.
The company said in a filing to the BSE that the company has not experienced any significant impact on its operations, supply chain and recoverability of carrying amounts of financial and non-financial assets due to the pandemic.
Now you can get handpicked stories from Telangana Today on Telegram everyday. Click the link to subscribe.
Click to follow Telangana Today Facebook page and Twitter .